TMOThermo Fisher Scientific

Health care · Measuring Instruments · NYSE

Thermo Fisher Scientific Inc. (also referred to in this document as “Thermo Fisher,” “we,” the “company,” or the “registrant”) is the world leader in serving science. 10-K, Item 1

Employees: 125,000
Headquarters: Waltham, MA
CEO: Marc N. Casper
Next results: around Jan 28, 2027

Compare with peers → Embed

RevenueFY2016–25 $44.6B+3.9% FY2024: $42.9B 10-K FY2025 · XBRL Net incomeFY2016–25 $6.7B+5.8% FY2024: $6.3B 10-K FY2025 · XBRL Free cash flowFY2016–25 $6.3B−13.4% FY2024: $7.3B 10-K FY2025 · XBRL Operating marginFY2016–25 17.4%+0.3 pts 13.5% in FY2016 10-K FY2025 · XBRL

What changed

10-K filed Feb 26, 2026 against Feb 20, 2025

Area	What changed	Source
Risk factors	2 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	11 other checks clear	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	3 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 26, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-20. Quoted as filed.

We and our third-party providers experience cyber-attacks and other attempts to gain unauthorized access to our products, services, and systems and data on a regular basis, and we anticipate continuing to be subject to such attempts as cyber-attacks
10-K, Item 1A

All 2 new paragraphs →

Accounting checks

latest 10-K

11 of 11 clear 0 worth a look. Checks, not verdicts.

✓
Receivables +8.7% vs revenue +3.9% (+4.7 pts)
✓
Cash from operations $7.8B vs net income $6.7B (FY ending 2025-12-31)
✓
Inventory +9.0% vs revenue +3.9% (+5.1 pts)
✓
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: Income taxes
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Oct 30, 20268-K Director or officer change 8-K item 5.02
Oct 30, 202610-Q Quarterly report (10-Q) period ended Sep 26, 2026
Oct 21, 20268-K Quarterly results 8-K item 2.02

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on TMO in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/TMO/export.csv") into a cell.